Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Current guidelines recommend either class for people with type 2 diabetes mellitus and established ASCVD, high cardiovascular risk, HF, or CKD [84,85]
Nearly all (99%) of the results came from two large-scale studies, involving mostly middle-aged and older adults
What can I expect during this treatment
Furthermore, in a 12-week RCT in which patients were either assigned to liraglutide (1.8 mg/day), sitagliptin (100 mg/day) or placebo, no difference in glycemic control or bodyweight reductions were found, and both treatments failed to reduce liver hepatic fat content compared to placebo (69)
US$ 21.48
US$ 23.68
US$ 22.16
US$ 22.58
US$ 27.91
US$ 29.50
US$ 29.74
